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Abstract During attempts to clone retroviral  determi- 
nants associated with a mouse model of Langerhans cell 
histiocytosis (LCH), suppression subtractive hybridization 
(SSH) was used to identify unique viruses in the liver of 
severe combined immunodeficiency  (SCID) mice trans- 
planted with LCH tissues. A partial genomic sequence of a 
murine coronavirus was identified, and the whole genome 
(31428 bp) of the coronavirus was subsequently sequenced 
using PCR cloning techniques. Nucleotide sequence com- 
parisons revealed that the genome sequence of the new 
virus was 91-93 % identical to those of known murine 
hepatitis viruses (MHVs). The predicted open reading 
frame from the nucleotide sequence encoded all known 
proteins of MHVs. Analysis at the protein level showed 
that the virus was closely related to the highly virulent 
MHV-JHM strain. The virus strain was named MHV-MI. 
No type D retroviruses were found. Degenerate PCR tar- 
geting of type D retrovirus and 50-RACE targeting of other 
types of retroviruses confirmed the absence of any retro- 
viral association with the LCH xenografted SCID mice. 
Abbreviations 
EM Electron microscopy 
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GM-CSF Granulocyte macrophage-colony stimulating 
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DTT Dithiothreitol 
G3PDH Glyceraldehyde-3-phosphate dehydrogenase 
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DEPC Diethylpyrocarbonate 
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Introduction 
 
Subtraction hybridization enables researchers to compare 
two populations of mRNA and to obtain clones of genes 
that are only expressed in one population. The basic prin- 
ciple behind the method is simple: both mRNA populations 
are converted to cDNA and then hybridized to each other; 
the hybridized sequences are then removed and the 
remaining unhybridized cDNAs represent genes that are 
   only expressed in one population. Several different meth- 
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ods of subtraction hybridization have been successfully 
applied [1–4] but each had limitations in identifying rare 
transcripts. Suppression subtractive hybridization (SSH) 
[5] overcomes this by using an additional suppression PCR 
step that provides 10-100 fold enrichment of differentially 
expressed mRNAs, irrespective of their relative abundance. 
SSH has been successfully used to compare differences in 
gene expression between two transcriptomes [6–10] but, to 
our knowledge, the use of SSH for identification of an 
unknown virus has not been previously reported. 
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Langerhans cell histiocytosis (LCH) is a rare human 
disease of unknown etiology. The disease is characterized 
by the accumulation of clonally derived Langerhans cells 
[11, 12] and inflammatory cells including T cells, macro- 
phages, eosinophils, neutrophils, giant cells, and plasma 
cells  [13,  14].  The  clinical  representation  of  LCH  can 
involve bone, skin, liver, spleen, lymph nodes, and/or bone 
marrow [15]. To overcome issues relating to the avail- 
ability of LCH tissue, the establishment of a mouse model 
of LCH was attempted by xenografting human LCH tissue 
into severe combined immunodeficiency (SCID) mice [16]. 
Following engraftment, several mice developed pre-T cell 
lymphomas, from which a cell line was developed, called 
ThyE1M6. Electron microscopy of this cell line appeared 
to show a budding retrovirus with an appearance similar to 
that   of   type-D-like   retroviral   particles   [16].   When 
ThyE1M6 cells  were injected into SCID  mice, a lethal 
syndrome  developed  within  2  weeks  in  which  mice 
developed generalized granulomas involving inflammatory 
cells in multiple organs. A virus was suspected, but anti- 
serum detection tests for known viruses were not possible, 
as SCID mice do not have B cells and therefore cannot 
make antibodies. Histopathological studies revealed that 
the liver was the most-affected organ. Attempts to isolate 
virus from liver were unsuccessful, and molecular tech- 
niques were used in this study to identify the putative virus. 
A type-D retrovirus was initially suspected, based on 
EM morphology of the ThyE1M6 cell line and the bio- 
chemical  readout  of  reverse  transcriptase  activity  [16]. 
Subsequent to the original description of type D retroviral 
particles by Ristevski et al., other studies confirmed the 
existence of endogenous type D retroviral sequences in the 
mouse genome [17]. In this study, total RNA was extracted 
from infected and uninfected mouse liver, mRNA popu- 
lations in total RNA were converted to cDNAs, and the 
cDNAs were subtracted from each other using the SSH 
method. The genomic sequence of a new strain of murine 
coronavirus was successfully identified and then 
sequenced.  No  type  D  retrovirus  or  any  other  type  of 
retrovirus was found, even after using targeted degenerate 
PCR or 50-RACE techniques. The new strain of coron- 
avirus was named MHV-MI. To our knowledge, this is the 
first report of the isolation of an unknown viral sequence 
using the suppression subtractive hybridization method. 
 
 
Materials and methods 
 
Xenografting of SCID mice 
 
A thymus biopsy sample from a 13-year-old female patient 
diagnosed with LCH was teased into a single-cell suspen- 
sion and continuously cultured in the presence of 25 ng/ml 
(each) of TNF and GM-CSF (Boehringer Mannheim Bio- 
chemica, Mannheim, Germany) for 35 days. Live cells were 
purified on a Ficoll gradient and injected subcutaneously 
into each of three SCID mice along with TNF and GM-CSF. 
Cytokine injections were repeated daily for 5 days. Three 
additional SCID mice were injected with cytokines only as 
the control. Liver tissues were harvested from the mice after 
7 weeks for histopathologic examination and then stored at 
-80 °C for future molecular biological studies. This work 
was approved by RCH (Royal Children Hospital) Ethics in 
Human Research and RCH Animal Experimentation Ethics 
Committee under the project title ‘The Biology of 
Langerhans Cell Histiocytosis’. 
 
RNA extraction 
 
Total RNA was extracted from approximately 50 lg of fro- 
zen liver tissues or 1 9 106 ThyE1M6 cells using a miR- 
Neasy Kit (QIAGEN, Clifton Hill, Australia) and following 
the manufacturer’s instruction manual. A minor modifica- 
tion was made in the final stage of the protocol where RNA 
was eluted with warm DEPC-treated water (50 °C) and 
collected in an Eppendorf tube containing 1 ll of RNasin 
(Promega, Madison, USA) and1 ll of DTT (10 mM). 
 
cDNA synthesis 
 
A BD SMART RACE cDNA Amplification kit (BD Bio- 
sciences-Clontech, Palo Alto, USA) was used for the syn- 
thesis of first-strand cDNA from total RNA extracted from 
mouse liver tissues or ThyE1M6 cells. The protocol in the 
user manual was slightly modified to adjust the reagent 
volume. Two micrograms of total RNA (2-4 ll), 0.5 ll of 
50-RACE CDS primer (12 lM), 0.5 ll of SMART II 
Oligonucleotide (12 lM) and deionized water to 5 ll final 
volume were added together in a sterile PCR reaction tube 
(0.1 ml). Contents were mixed and briefly spun. The tube 
was incubated at 72 °C in a hot-lid thermal cycler for 2 min 
and then cooled down on ice for 2 min. A mixture of 59 
First-Strand Buffer (2 ll), 10 mM dNTP mix (1 ll), 20 mM 
DTT (1 ll), and Powerscript Reverse Transcriptase (1 ll) 
was added to the tube and mixed gently by tapping. The 
mixture was briefly spun down and incubated at 42 °C for 
4 h (enough time to transcribe full-length type D retroviral 
RNA). After the reaction was finished, the transcriptase 
activity was stopped by incubating the tube at 70 °C for 7 
min. The transcribed cDNA was then either stored at 
-20 °C for future use or used immediately. 
 
Preparation of forward subtracted cDNA by SSH 
 
The preparation of forward subtracted cDNAs was done 
according to the BD PCR-Select cDNA Subtraction Kit 
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(BD Biosciences-Clontech, Palo Alto, USA) protocol. 
cDNAs were synthesized from total RNA of both infected 
and uninfected mouse liver using the protocol described 
above. cDNA from infected mouse liver was called ‘tester 
cDNA’, and that from uninfected mouse liver was called 
‘driver cDNA’. 
Both cDNAs were then purified using Chroma Spin -400 
column chromatography (QIAGEN, Clifton Hill, Australia) 
and digested with Rsa I restriction enzyme (kit component) 
to completion. Confirmation of complete digestion was 
monitored by gel electrophoresis. Digested cDNAs were 
then purified using the NucleoSpin II protocol (BD Bio- 
sciences-Clontech, Palo Alto, USA). 
Digested and purified tester cDNA was subdivided into 
two equal portions and ligated with two different adaptors 
(supplied in the cDNA subtraction kit). Ligation efficiency 
was confirmed by PCR using a housekeeping gene 
(G3PDH)-specific forward primer and the reverse adaptor 
primer (kit components). Following ligation, two 
hybridization steps were performed as per the protocol. 
Normalized and subtracted single-stranded target cDNA 
molecules anneal with each other, forming double-stranded 
hybrids with two different adaptor sequences at their 50 
ends. The adaptor ends were then filled with DNA poly- 
merase, and the subtracted molecules were specifically 
amplified by nested PCR using adaptor-specific primer 
pairs. 
 
Preparation of subtracted cDNA libraries 
 
Subtracted cDNAs (the nested PCR products described in 
the previous section) were treated with Taq DNA poly- 
merase for 10 min at 72 °C in a reaction mix of 20 ll 
containing 17 ll of nested PCR products, 2 ll of PCR 
buffer (910), 0.5 ll of MgCl2, 0.25 ll of dNTP mix, and 
0.25 ll of Taq DNA polymerase (Invitrogen, California, 
USA). Two ll of treated cDNAs was then ligated with 25 
ng of pGEM-T plasmid vector (Promega, Madison, USA) 
using T4 DNA ligase in an overnight reaction at 16 °C. 
Ligase activity was then stopped by heating the reaction 
mix at 72 °C for 10 min. One ll of inactive ligation mix 
was then used to transform 50 ll of maximum efficiency 
E. coli (DH5a) competent cells (Invitrogen, Carlsbad, 
USA) using a MicroPulser (BIO-RAD, Hercules, USA). A 
sufficient volume of transformed bacteria was plated onto 
LB agar plates containing 50 lg of ampicillin (Aspen, 
Deakin, Australia) per ml and an appropriate amount of 
Xgal  (Promega,  Madison,  USA)  and  IPTG  (Invitrogen, 
Carlsbad, USA), followed by  overnight  incubation  at 
37 °C. Multiple plates were grown from each ligation mix. 
The pGEM-T plasmid contains a LacZ reporter at the 
multiple cloning site and allows blue/white screening. 
White colonies represented recombinant cells containing a 
subtracted cDNA insert, while blue colonies represented 
background cells containing plasmids only. Fully grown 
colonies (blue and white) from each plate were collected 
with a scrubber in 5 ml of LB ? 25 % glycerol and pooled 
in a 50-ml tube. Preparation of the subtracted cDNA library 
was then complete. The library was divided into several 
vials, flash frozen with liquid nitrogen, and stored at -80 °C 
for future use. 
 
Titering and sequencing forward subtracted cDNA 
clones 
 
One vial of frozen forward subtracted library was quickly 
defrosted on a warm (37 °C) metal block rack, mixed by 
gentle vortexing, and then diluted 10-3-fold and 10-6-fold 
with LB broth. Ten ll of each diluted library was mixed 
with 100 ll of LB broth and inoculated onto LB plates 
containing 50 lg of ampicillin per ml and the appropriate 
amount of Xgal (Promega, Madison, USA) and IPTG (In- 
vitrogen, Carisbad, USA). Plates were incubated overnight 
at 37 °C. A satisfactorily grown plate was selected, and 
both white and blue cells were counted. The titer of the 
library was calculated from the white colony counts, and 
the efficiency of the library was calculated from the ratio of 
white cell counts and total cell counts. 
A total of 148 white colonies were randomly selected 
from a titering plate and grown in 2 ml of LB-ampicillin 
medium overnight at 37 °C with vigorous shaking. 
Recombinant plasmids were prepared from all colonies 
using  the  QIAprep®   procedure  (QIAGEN,  Clifton  Hill, 
Australia). Sequencing reactions  were carried out using 
PRISM BigDye Terminator Mix (Applied Biosystems, 
Foster City, USA) and vector-specific primers. A 3730s 
Genetic Analyzer (Applied Biosystems, Foster City, USA) 
was used for reading sequences. The sequences were then 
identified based on homology searches using the web-based 
nucleotide sequence analysis program MegaBLAST [18] 
from the National Center for Biotechnology Information 
(NCBI). 
 
Primer design and sequencing of the MHV-MI virus 
genome 
 
GeneFisher2 software (Bielefeld University Bioinformatics 
Server – BiBiServ) was used to design 34 pairs of over- 
lapping primers, each covering approximately 1000 bp of 
the MHV-A59 genomic sequence (accession no. 
AY700211). Primers were designed to enable a single 
thermal profile to be used for each PCR. Twenty-three pairs 
(Table 1, yellow shaded) produced the expected PCR 
products with a thermal profile of 5 min pre-PCR treatment 
at 96 °C; 35 cycles of 95 °C for 15 s, 55 °C for 30 s and 
72 °C for 1 min, followed by a 5-min extra elongation at 
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Table 1  Primer list for cloning and sequencing the full-length MHV-MI virus genome 
 
 
Sequence position Product (bp) Forward primer sequence 
with source sequence 
-18† – 495 513 GTACCCTTTCTACTCTCA 
‡MHV-3 (1-18) § 
385-1404 1020 CAGTCTGCCATAATCCGTGA 
‡MHV-A59 (427-446) 
1148-2166 1019 CCGAGGATGTGGTGGATGGA 
MHV-A59  (1190-1209) 
1858-2876 1019 AAATTCGCCACCTGTGGAGA 
MHV-A59 (1900-1919) 
2857-3873 1017 CTCAGCCCTTGTAAGGAGCA 
MHV-A59 (2899-2918) 
3609-4630 1022 ACAAGGCCGGCTATGACCAA 
MHV-A59 (3656-3675) 
4384 -5404 1021 ATGCGCGAGGGCATGGCAA 
MHV-A59 (4430-4500) 
5325-6490 1166 GGCTTGTTTAATGCTGTAGCA 
Cloned  PCR product 
6442-7425 984 GCCGGTATTGCCAAGGAGCA 
MHV-A59 (6478-6497) 
7242-7945 704 GCTGGATCACTATGATGCTA 
Cloned  PCR product 
7793-8812 1020 TGAAACGCCCTGTGAATCCA 
MHV-A59 (7865-7884) 
8307-9326 1020 GTCTATTACCAAGTCCGTCA 
MHV-A59 (8379-8398) 
9112-11066 1955 ACTATGCTTGCGCATGCTGA 
Cloned  PCR product 
9731-10439 709 ATTTGCAGTGGCTTGTCA 
Cloned PCR product 
10945-11964 1020 CATTCTGGATTCCAGGGCAA 
MHV-A59 (11017-11036) 
11915-12634 720 TGACGGATGTCAAATGTGCTA 
Cloned  PCR product 
12422-13441 1020 AGGTAGTGTCTGCATTGCAA 
MHV-A59 (12494-12513) 
13359-14191 833 ATTGTGCAAATTACGCGGCAA 
Cloned  PCR product 
13819-14838 1020 ATGTGGAGGGAAGTCGGGTA 
MHV-A59 (13891-13910) 
14629-16385 1757 CCCTTCATGTGGCATCTGCTA 
Cloned  PCR product 
15352-15663 312 CTAAGTGTGATCGTGCTA 
Cloned PCR product 
15867-16385 519 GTGTTTATGTCTGAGGCCAA 
MHV-A59 (15939-15958) 
16270-17289 1020 TAAGAAGTGCAGTGCTGCAA 
MHV-A59 (16342-16361) 
17069-18802 1734 GTTTCAGAACAATGTGCCAA 
Cloned  PCR product 
17628-18018 391 ATTGTGGATACGGTGTCA 
Cloned  PCR product 
18678-19697 1020 TTCGCTAAAGTTGGAAGAGA 
MHV-A59 (18729-18748) 
19485-20299 815 ACATGCATCACAAGATGCAA 
MHV-A59 (19557-19576) 
20246-21265 1020 ACAAGGTAATCCGGGTGGTA 
MHV-A59 (20318-20337) 
21084-21964 881 GTGAGTGACAGTGTTGCCTCA 
Cloned  PCR product 
21793-22166 374 CTTGTGGAAATGGGTTTGGA 
Cloned  PCR product 
21988-23063 1076 AGAGGATTTGAAGAGTTGCA 
MHV-A59 (22060-22079) 
22827-24075 1249 TACTGGTGAGGGGTCTCA 
Cloned  PCR product 
Reverse primer sequence 
with source sequence 
CTTGGATGGCTTAACCAA 
Cloned PCR product 
TGGACATGGAAAGCCATCCA 
MHV-A59 (1446-1427) 
CCATCCAGCGGCACTAGCA 
MHV-A59 (2208-2190) 
ATGCTCCTTACAAGGGCTGA 
MHV-A59 (2919-2900) 
ATCTGCAGACAACAAGGTCA 
MHV-A59 (3918-3899) 
ATAGCGCTTTGGTACCAGCA 
MHV-A59 (4675-4656) 
CAGAGCGGAACTCGTTCCAA 
MHV-A59 (5449-5430) 
TCGCCTTTTTGTCATCAACCA 
Cloned  PCR product 
TTCAGGCAACCATGTGGTCA 
MHV-A59 (7497=7478) 
GCAGACCATTCATATCCACA 
Cloned  PCR product 
ACACATCCCTTAGCACACCA 
MHV-A59 (8884-8865) 
TCACATAAACCAACCCTGCA 
MHV-A59 (9398-9379) 
ATAACTCTTGTGCGGCTGGA 
Cloned  PCR product 
TACTTCGGTGTGTTAGGA 
Cloned PCR product 
GTGCTGGAGGCAATTAAGCA 
MHV-A59 (12036-12017) 
ACATTCCCAGCATAGGTGACA 
Cloned  PCR product 
AAACATCATGCGTCAACACA 
MHV-A59 (13513-13494) 
CAACCTGGTACTGTCTTGACA 
Cloned  PCR product 
CAGCATTACCATCCTGCGTA 
MHV-A59 (14910-14891) 
GATCATAGGCGCATTTGCAA 
MHV-A59 (16458-16439) 
GTAACTCGCGTATACTCA 
Cloned  PCR product 
GATCATAGGCGCATTTGCAA 
MHV-A59 (16458-16439) 
GAACAATACGCGTGCAGTCA 
MHV-A59 (17361-17342) 
GGGTTGTACAGATAATCACA 
Cloned  PCR product 
TACTCATGACACAGAGGA 
Cloned  PCR product 
AAAGTGTCCAGCATTGACCA 
MHV-A59 (19697-19678) 
AGAGCTTCATTACCGCTGAGA 
Cloned  PCR product 
CCAGAGCCAACTTGTCACGA 
MHV-A59 (21336-21317) 
CAAGCATGTGAGGGTTGTCA 
MHV-A59 (22036-22017) 
ACGTTGTTATGCTTAGGGTA 
Cloned  PCR product 
ACCTCCATAGGCATAAGACA 
MHV-A59 (23079-23060) 
CTGGAACCGTCTACAGGA 
Cloned  PCR product 
 
 
Virus detection by suppression subtractive hybridization 2949 
 
 
 
Table 1  continued 
 
 
Sequence position Product (bp) Forward primer sequence 
with source sequence 
Reverse primer sequence 
with source sequence 
23982-25001 1020 TTTCACAAGGCCTGGGGACA 
MHV-A59 (24060-24079) 
24849-26027 1179 AGTGGCTTACTGCTAGGTCA 
MHV-A59 (24927-24946) 
25938-26686 749 ATAGTGACGCATCAGAACCA 
Cloned  PCR product 
26426-27713 1288 GAGGTTAATAACCTCTTGGA 
MHV-A59 (26345-26364) 
27593-28619 1027 AATCCACCCGACTTTAAGGA 
MHV-A59 (27512-27531) 
28271-28791 521 GCGCAACCACGCTCGATGGTA 
Cloned  PCR product 
28621-29144 524 GCAACCAGGGTAAATTTGCA 
MHV-A59 (28533-28552) 
29078-29824 747 AGCTCCCCAGCCGGTTTACCA 
Cloned  PCR product 
29472-30492 1021 CCCATTATTGAGGATTACCA 
MHV-A59 (29380-29399) 
30064-31086 1023 GGGATATTGGTATAGACACA 
MHV-A59 (29972-29991) 
30064- (31428 + 32) 1397 GGGATATTGGTATAGACACA 
MHV-A59 (29972-29991) 
31039-31391 353 AGAACTAACCCCAGAGGA 
Cloned  PCR product 
ACCTGCCATACACTTTGGAA 
MHV-A59 (25079-25060) 
GTGGGTTCTCCTCACGGGAA 
MHV-A59 (25946-25927) 
ATAAGCCTCGACAAAGCCAA 
Cloned  PCR product 
TCTCATCCGTCAGGTCCAGGA 
Cloned  PCR product 
ACACCAAGCCTTTAAAGGAA 
MHV-A59 (28531-28512) 
CGAGCTGGGTTGCTCTCCAGA 
Cloned  PCR product 
GAAGTTCCATTCCTTAAGGA 
MHV-A59 (29052-29033) 
ACCAGCGCGGTTTCCAGAGGA 
Cloned  PCR product 
TAGCCAAAACAAGAGCAGCA 
MHV-A59 (30399-30380) 
TCATCAAGGATCTGAGCCAA 
MHV- A59 (30991-30972) 
3’-RACE CDS primer (32 bp) 
(BD SMART RACE KIT) 
ACTAGGGCATTGCAGGAA 
Cloned  PCR product 
 
 
t Negative sequence position means the position before the start of the reported sequence 
t The accession number for the MHV-3 genome sequence is FJ647224.1, and that for the MHV-A59 genome sequence is AY700211.1 
§    The number range within the brackets denotes the nucleotide positions in the respective genome sequence 
 
 
72 °C. The PCR cocktail (20 ll) contained 1 ll of fivefold- 
diluted cDNA from the infected mouse (E4M31) liver, 2.5 
mM MgCl2, 0.5 ll of each primer (10 lM), 0.5 ll of dNTP 
mix (10 mM), 0.2 ll of Advantage® 2 Polymerase Mix 
(Clontech, CA 94043, USA), and the required volume of 
water. PCR products were cloned and sequenced using a 
previously established protocol [19]. A 3730s Genetic 
Analyzer was used instead of a 310 Genetic Analyzer in the 
new method. 
In the second phase, 11 pairs of nested primers located 
within the sequences of previously cloned PCR products 
and four pairs of combined primer (nested and MHV-A59 
genome-specific) were designed (Table 1, gray shaded). 
Varying thermal profiles were used depending on the 
melting temperatures of primer pairs. All 16 PCR products 
were cloned and sequenced again. 
In  the  third  phase,  the  30   end  of  the  genome  was 
amplified by 30-RACE reaction using a BD SMART RACE 
cDNA Amplification Kit (BD Biosciences-Clontech, Palo 
Alto, USA) and an internal primer (50-GGGA- 
TATTGGTATAGACACA-30) that was designed from the 
MHV-A59 genomic sequence (Table 1, red letters). The 50 
end of the genome was amplified by standard PCR using a 
known 50-end conserved primer (50-GTACCCTTTC- 
TACTCTCA-30) (Table 1, blue letters) and an internal 
reverse     primer     (50-CTTGGATGGCTTAACCAA-30) 
(Table 1, pink letters), which was designed from the 50-end 
of the already sequenced genome portion. 
In the fourth phase, four pairs of nested primers (Table 1, 
dark gray shaded) were designed to further sequence the less- 
reliable middle portion of longer sequences (longer than 
1300 bp). PCR products were amplified using varying ther- 
mal profiles depending on the melting temperatures of pri- 
mer pairs. Finally, a total of 44 primer pairs were used to 
amplify the full-length viral genome (Table 1). 
All PCR products or RACE products were cloned and 
sequenced using the same method [19]. Compilation and 
further analysis of those sequences were performed using 
pDRAW32 DNA Analysis Software (http://www.acaclone. 
com). 
 
Degenerate PCR 
 
Designing degenerate primers and optimization of PCR 
conditions 
 
Nucleotide sequences of almost all known Type-D retro- 
viruses, namely SRV-1, SRV-2, MPMV, Tsukuba monkey 
virus, squirrel retrovirus, TvERV, MusD1 and MusD2 [17, 
20–26], were aligned using the web-based CLUSTAL W 
(1.83) program (EMBL-EBI). Two pairs of degenerate 
primers each from the ‘gag’, ‘pol’ and ‘pro’ regions of the 
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viral sequence were designed from the conserved regions 
of the alignment data (not shown here). The primer pairs 
used were as follows: 
gag-PP1-FWD  50-TTRGCRTTYTCAWADGCYA-30 
gag-PP1-REV  50-AITAYGGBSCYWMWGCYCC-30 
gag-PP2-FWD  50-TRGCHTWTGARAAYGCYAA-30 
gag-PP2-REV  50-GRCCCCKBHIBHMGTTTCC-30 
 
pol-PP1-FWD 50-HATWGAYYTIAARGAYTGY-30 
pol-PP1-REV 50-RIARYTTTTGRAARTCATT-30 
pol-PP2-FWD 50-IYTRGGWGAYATHAATTGG-30 
pol-PP2-REV 50-GARGABCCRTCWGTRAADA-30 
 
pro-PP1-FWD 50-GABTGGACYTSWGTKCCAC-30 
pro-PP1-REV 50-TRAWYTCYCCHKYATARTC-30 
pro-PP2-FWD 50-GRGARWTYAARATHWTDGC-30 
pro-PP2-REV 50-CYCCIGWRTCKAKTAVBCC-30 
(where R = A?G,  Y = C?T,  M = A?C,  K = G?T, 
S = G?C,  W = A?T,   H = A?T?C,   B = G?T?C, 
D = G?A?T, V = G?A?C, I = Inosine) 
Optimization of PCR conditions for all degenerate pri- 
mer pairs was done in two phases using a mouse genomic 
DNA template containing the type D retroviral sequences 
MusD1 and MusD2 [17]. In the first phase, only one 
thermal profile (95 °C for 7 min, 40 cycles of 95 °C for 30 
s, 40 °C for 10 s, 60 °C for 1 min, and an additional 5-min 
extension at 60 °C) was used for all six primer pairs. A 
standard PCR mix containing 2 mM MgCl2 was used to 
amplify the target PCR products in this phase. In the sec- 
ond phase, only the successful primer pairs in the first 
phase (gag-PP2-FWD/REV and pro-PP2-FWD/REV) were 
optimized, using various MgCl2 concentrations and 
annealing temperatures. 
Experimental degenerate PCR 
 
Experimental degenerate PCR reactions were carried out 
with the cDNAs obtained from infected and uninfected 
mouse liver. Only successfully optimized primer pairs were 
used to amplify the target PCR products under the opti- 
mized thermal conditions. 
 
Internal control RT-PCR 
 
A predesigned primer pair for the mouse beta actin gene 
with PrimerBank ID 6671509a1 (http://pga.mgh.harvard. 
edu/primerbank/) was used to amplify an RT-PCR product 
from the cDNA of both infected and uninfected mouse 
liver. The reaction mix (20 ll) contained 1 ll of cDNA, 2.5 
mM MgCl2, 0.5 ll of each primer (10 lM), 0.5 ll of dNTP 
mix (10 mM), 2 units of AmpliTaq Gold DNA polymerase 
(Applied Biosystems, Foster City, USA) and the required 
volume of water to make the final volume 20 ll. The 
thermal profile used was 95 °C for 7 min, 40 cycles of 
95 °C for 30 s, 55 °C for 10 s, and 60 °C for 30 s, followed 
by an additional 5-min extension at 60 °C. 
 
50- RACE using tRNA primers 
 
Eleven tRNA primers complementary to the primer bind- 
ing sites (PBS) of most of the known retroviral genomes 
(Table 2), were synthesized by Sigma-Aldrich (Australia). 
50-RACE reactions were carried out with all of these pri- 
mers against the cDNA obtained from the infected mouse 
(E4M31) liver according to the BD SMARTTM RACE 
cDNA Amplification Kit protocol (BD Bioscience-Clon- 
tech, Palo Alto, CA, USA). A positive-control 50-RACE 
was done with the cDNA obtained from the ThyE1M6 cell 
 
Table 2  Retroviral PBS 
sequences Virus names Common PBS sequence PBS type 
TvERV, HERV, M-PMV, SFV 50-tggcgcccaagctggggc-30 C-tRNAt Lys 
HIV-1, MMTV, SIV, SRV-1 50-tggcgcccgaacagggac-30 C-tRNA Lys-3 
S-HIV mutant 50-tggcgccctgaacagggac-30 C-tRNA Lys-5 
FMLV, RMLV, MCRV, STLV-3, STLV-1, 
HTLV-1, Abelson MLV, Mo-MLV, 
MOSV, KoRV 
50-tgggggctcgtccgggat-30 C-tRNA Pro 
 
Mu-ERVL 50-tggaggtcccacgagat-30 C-tRNA Thr 
MLV 50-tggaggcccagcgagat-30 C-tRNA Gln 
ALV, SRV, ACV, EAV-HP 50-tggtgaccccgacgtgat-30 C-tRNA Trp 
AKV 50-tggcgctgcgagcaggac-30 C-tRNA Ser 
AKV 50-tgccaccccagacgggac-30 C-tRNA Arg 
AKV 
MusD1, MusD2tt 
50-tggtgcctaaacccggga-30 
50-tggcgccagaactgggac-30 
C-tRNA Phe 
C-tRNA Lys-5v 
t  C-tRNA, complementary to tRNA 
tt  MusD1 and MusD2 are not true viruses but are endogenous proviruses found in the mouse genome [17] 
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line using t-RNA Pro primer. Reactions were done in a 
25-ll final volume containing first-strand cDNA (2 ll), 
109 PCR buffer (2.5 ll), 25 mM MgCl2 (2.0 ll), 10 mM 
dNTP mix (0.5 ll), 10 lM t-RNA primer (0.5 ll), universal 
primer mix (UPM) (2 ll), AmpliTaq Gold DNA poly- 
merase (Applied Biosystems, Foster City, USA) (0.5 ll) 
and water (remaining volume up to 25 ll). The thermal 
profile used for the 50-RACE reaction was 5 min pre-PCR 
treatment at 96 °C; 35 cycles of 95 °C for 15 s, 48 °C for 
30 s and 72 °C for 30 s; and 5 min extra elongation at 
72 °C. 
 
 
Results 
 
Identification of MHV sequences using the SSH 
technique 
 
Subtraction efficiency tests for control and experimental 
samples were performed after completion of the forward 
subtraction process, and the results were satisfactory (data 
not shown). Successfully subtracted cDNAs were then 
cloned into E. coli using the pGEM vector and made into a 
forward subtracted cDNA library following the procedure 
described above. The titer and efficiency of the library 
were calculated to be 4.3 9 109 cfu/ml and 71.5 %, 
respectively. Sequence analysis of 148 successful clones 
revealed that 12 % of the total subtracted genes belonged 
to murine coronavirus (MHV) (Table 3). No other viral 
genes were identified in the subtracted population (148 
clones). This indicated that murine hepatitis virus was a 
likely cause of the infection in transplant-recipient SCID 
mouse liver. 
 
Sequencing the full-length murine coronavirus 
(MHV) genome 
 
A total of 43 PCR products of varying sizes (312 bp-1757 
bp) and a 30-RACE product (1365 bp) were sequenced on 
both strands to derive the full-length genome sequence of 
the murine hepatitis virus. At least three clones from each 
PCR product or 30-RACE product were sequenced. DNA 
analysis software pDRAW32 and ClustalW2 (EMBL-EBI) 
were use to compile and align sequence data. Sequences in 
the primer regions were corrected using overlapping 
sequence alignment. Since the sequence of the 50-end for- 
ward primer (50GTACCCTTTCTACTCTCA30) could not 
be verified by any other means, an 18-bp sequence from the 
50 end of the full-length genome was excluded and then 
reported to DNA Data Bank of Japan (DDBJ) with the 
accession number AB551247. The reported full-length 
genome of MHV-MI is therefore 31,428 bp long. 
 
Sequence analysis 
 
Initially 12 ORFs were predicted in three reading frames 
from the full-length viral genome (31,428 bp) using 
pDRAW32 DNA analysis software (Aca Clone software). 
Only five of these matched with known proteins of MHVs: 
hemagglutinin-esterase (HE), spike glycoprotein (S), non- 
structural protein 4 (ns4), membrane protein (M), and 
nucleocapsid protein (NC). The remaining seven ORFs 
were either partially matched or did not match with any 
known MHV proteins. At that stage, the information rela- 
ted to ORFs of many MHVs with published [27–33] or 
unpublished sequences (accession nos. FJ647224, 
FJ647219, NC_006852.1) were consulted, and seven more 
proteins, namely, replicase polyprotein 1a, replicase 
polyprotein 1ab, non-structural protein 2a (ns2a), non- 
structural protein 5 (ns5), envelope protein (E), and internal 
protein (I) were predicted. The ORF of replicase polypro- 
tein 1ab contained a ribosomal slippage site at nucleotide 
position 13,524 bp. ORFs of replicase  polyprotein 1ab, 
replicase polyprotein 1a, ns4, ns5, E, M, NC and I protein 
contained overlapping sequences of varying length (4–
13384 bp). The I protein was predicted within the coding 
sequence of the NC protein, but in a different reading 
frame; hence, there was 100 % overlap (410 bp) of the I 
protein by the NC protein. BLAST analysis against the 
protein data base revealed that most of the predicted 
proteins are more similar to the corresponding proteins of 
MHV-3 (90-99 %) than to those of any other MHV strain 
 
Table 3  Gene list from forward 
cDNA subtraction HITS Percentage Gene name 
18 12 Murine hepatitis virus nucleocapsid, membrane proteins etc. 
 
14 9 Mouse serum amyloid A (SAA) family proteins 
14 9 Mouse fibrinogen (alpha, beta and gamma) polypeptide 
6 4 Mouse annexin A protein family 
3 2 Mouse lactotransferrin 
2 1.33 Mouse serine or cysteine peptidase inhibitor (SP1-2) clade member 
2 1.33 Mouse mRNA for Ly-6 alloantigen (ly-6E.1) 
1 0.68 89 individual mouse genes 
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Table 4  Sequence identity of 
 
 
Virus name Size ORF1ab    ORF1a    ns2a    HE    S ns4    ns5    EP    M N I 
viral proteins to those of other    
MHV viruses 
 
 
 
 
 
 
 
 
 
t  0, protein absent in the target virus 
 
 
M 1 2 3 4 5 6 7 8 9 10 M 
 
 
 
Fig. 1 Degenerate PCR with optimized primer pairs, gag-PP2-FWD/ 
REV and pro-PP2-FWD/REV. Under the optimized conditions, the 
gag-PP2-FWD/REV primer  pair produced a 420-bp PCR product 
from mouse genomic DNA (lane 1) but not from the cDNA from 
infected mouse liver (lane 2) or uninfected mouse liver (lane 3). 
Similarly, the pro-PP2-FWD/REV primer pair produced a 240-bp 
PCR product from mouse genomic DNA (lane 5) but not from the 
cDNA of infected mouse liver (lane 6) or uninfected infected mouse 
liver (lane 7). Lanes 4 and 8 represent negative controls (no template) 
for each primer. Lanes 9 and 10 show the RT-PCR products (154 bp) 
from infected and uninfected mouse liver cDNAs, respectively, using 
b-actin gene primers. Lane M shows a 100-bp ladder marker, and the 
lowest band represents 200 bp 
 
(Table 4). Comparative analysis of ORFs from different 
MHVs revealed that MHV-MI contains the same number 
of proteins as JHM virus or its variants RJHM/A, MHV- 
JHM.IA,   SA59/RA59,   SJHM/RA59,   and   strain   A59 
(Table 4), and hence, MHV-MI is more closely related to 
JHM virus or its variants. The reported full-length genome 
sequence of MHV-MI in the DDBJ database (accession no. 
AB551247) contained all of these 12 predicted ORFs and 
their nucleotide positions. 
 
Degenerate PCR targeting type D retrovirus 
 
Primers for degenerate PCR targeting type D retrovirus 
were designed from the known sequences of type D 
retroviruses as described above. After the first PCR opti- 
mization step, only two primer pairs (gag-PP2-FWD/REV 
and pro-PP2-FWD/REV) successfully amplified the target 
PCR products of 420 bp and 240 bp, respectively, from the 
mouse genomic DNA. PCR products were verified by 
sequencing to be derived from MusD1 or MusD2 retroviral 
sequences of mouse genomic DNA. After the second phase 
of optimization, 2 mM MgCl2 was found to be optimal for 
both primer pairs, but an annealing temperature of 55 °C 
was found to be optimum for the gag- PP2-FWD/REV 
primer pair, and 45 °C for the pro-PP2-FWD/REV primer 
pair. Under the optimum conditions, both primer pairs 
produced sharp PCR bands (Fig. 1). In the experimental 
degenerate PCR, no PCR products were amplified, even 
after 70 cycles. RT-PCR internal control with mouse b- 
actin  primers  produced  the  expected  products  (154  bp) 
from both infected and uninfected mouse liver cDNAs. 
These results clearly indicated that no type D retrovirus 
was present in the infected or uninfected mouse liver. 
 
50- RACE targeting a whole range of retroviruses 
 
Eleven tRNA primers were designed to cover the whole 
range of retroviruses (Table 2), but none of the primers 
produced the expected 50-RACE products from cDNA from 
infected mouse liver (Fig. 2). tRNA primers for Lys, Thr 
and Gln produced some products (lanes 1, 6 and 7), but 
similar  products  were  also  observed  in  the  50-RACE 
MHV-3 31,448 99 97 97 0t 96 0 90 96 99    97    90 
MHV-1 31,386 99 97 96 0 90 94 89 95 99 96 0 
MHV-2 / MHV-ML11 31,233 98 94 95 0 90 94 87 96 99 95 0 
Strain JHM 31,526 98 95 95 81 95 94 90 95 97 96 89 
RJHM/A 31,427 98 96 94 82 95 94 90 95 98 96 90 
MHV-JHM.IA 31,473 99 96 94 81 95 94 92 96 98 96 90 
Strain A59 31,335 99 96 96 81 90 96 92 93 99 96 0 
SA59/RJHM 31,283 98 96 94 81 91 94 90 95 98 96 89 
SJHM/RA59 31,250 99 96 94 81 90 0 92 93 99 96 89 
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Fig. 2 50-RACE using tRNA primers. Eleven tRNA primers were 
used to produce the expected 50-RACE product from the infected 
mouse (E4M31) liver cDNA as per the procedure described in 
Materials and methods. Lane 1, Lys tRNA; lane 2, Lys-3 tRNA; lane 
3, Lys-5 tRNA; lane 4, Lys-5v tRNA; lane 5, Pro tRNA; lane 6, Thr 
tRNA; lane 7, Gln tRNA; lane 8, Trp tRNA; lane 9, Ser tRNA; lane 
10, Arg tRNA, and lane 11, Phe tRNA. Lane- (?) shows a positive 
control 50-RACE product (220 bp) with the cDNA of the ThyE1M6 
cell line using Pro tRNA. Lane IC shows an internal control RT-PCR 
product (154 bp) from the cDNA of infected mice liver, using b-actin 
primers. Lane M shows a 100-bp ladder marker 
 
 
experiment with uninfected mouse liver cDNA (data not 
shown). These products were regarded as not being gen- 
erated from any retroviral genome. A positive control 
cDNA from the ThyE1M6 cell line, which expresses 
endogenous MoMLV (data not shown), yielding a product 
with the tRNA-Pro primer (Fig. 2). The product was also 
confirmed  by  sequencing.  An  RT-PCR  internal  control 
with mouse b-actin gene primers, following the procedure 
described above, produced the expected product from 
infected mouse liver cDNA (Fig. 2). These results indi- 
cated that no known retrovirus was present in the infected 
mouse liver. 
 
 
Discussion 
 
TM 
forward-subtracted cDNAs only. Other gene sequences 
resulting from forward subtraction analysis (Table 2) were 
not analyzed for the same reason. 
MHVs belong to the group II coronaviruses, which are 
divided into two groups according to patterns of tropism 
[35]. Enterotropic strains, such as MHV-D, MHV-Y, 
MHV-RI, LIVIM, and DVIM, generally produce infections 
confined to the GI tract [36], whereas polytropic strains, 
such  as  MHV-1,  MHV-2,  MHV-3,  MHV-4  (or  JHM), 
MHV-A59 and MHV-S, initiate infection mainly in the 
respiratory tract, which can disseminate to the liver, spleen, 
lymph nodes, and brain [35–37]. Polytropic strains are 
usually more virulent than enterotropic strains [38]. 
Although BLAST analysis of protein sequences showed a 
higher percentage of homology with MHV-3 proteins, 
comparative  analysis  of  ORFs  (Table 4)  revealed  that 
The PCR-Select cDNA subtraction method is based on a MHV-MI was more closely related to polytropic MHV- 
unique approach of selective amplification of differentially 
expressed sequences [5, 34] and requires a series of qual- 
ity-assessment steps before the final subtraction stage. We 
started with three pairs of infected and uninfected mouse 
liver RNA samples, and one pair of positive control human 
placental RNA sample (HaeIII treated and untreated). After 
quality testing in each step of cDNA synthesis, Rsa I 
digestion, and adaptor ligation, only one pair of ‘tester 
cDNA’ and ‘driver cDNA’ was selected for final subtrac- 
tion analysis, based on quality assessment. The ‘tester 
cDNA’ was derived from the RNA of infected mouse 
(E4M31) liver, and the driver cDNA was derived from 
RNA of uninfected mouse (E5M32) liver. Since identifi- 
cation of a viral gene signature from the infected mouse 
liver was the goal, only the forward subtraction method 
was  used,  and  the  library  was  constructed  from  the 
JHM virus or its variants. MHV-MI also contained the HE 
protein, which forms smaller spikes on virions [27] and 
enhances virulence when paired with spike protein (S) [39]. 
The HE protein is absent in the MHV-3 strain, and MHV- 
MI could therefore be predicted to be a polytropic virulent 
virus and a very close relative of MHV-JHM. 
The non-specific SSH approach is useful for identifying 
unknown putative viruses. Since  it did not  identify the 
suspected type D retrovirus or any other retroviruses, tar- 
geted degenerate PCR and 50-RACE techniques were used 
to confirm the negative SSH results. Both experiments 
confirmed the absence of any retroviral involvement in the 
diseased mouse livers. It is unclear if the inflammatory 
LCH-like phenotype observed in the SCID mice is related 
to the MHV infection, and further studies are required to 
examine this possibility. 
2954 M. M. Islam et al. 
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